Study on treatment and health in type 1 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at how people with type 1 diabetes are treated and how their metabolism is doing. It will help doctors understand the condition better and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes
- You had diabetic ketoacidosis (a serious high-blood-sugar emergency with ketones) when first diagnosed, or you still have ketones in your urine
- You tested positive for certain antibodies linked to type 1 diabetes (like islet cell antibodies or GAD antibodies)
- Your C-peptide levels (a measure of how much insulin your body makes) are very low, both before and after eating
- You are willing to use a continuous glucose monitor and fill out questionnaires
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
This study tests a device that measures both glucose and ketone levels continuously. It may help people with type 1 diabetes better manage their condition by providing real-time data.
This study uses artificial intelligence to analyze glucose monitor data from people with type 1 diabetes. The goal is to find patterns that could improve care and treatment.
This study offers a structured education course and regular checkups to help adults with type 1 diabetes better manage their blood sugar and overall health. Participants will learn about their condition and receive support to improve metabolic indicators.
This study tests a new sensor that continuously measures ketone levels in people with type 1 diabetes who are also taking SGLT2 inhibitors. It aims to see if the sensor can help prevent diabetic ketoacidosis.
Hear when a new Type1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.